Healthcare
Coreline Soft outlines global medical-AI expansion
South Korean medical-AI company Coreline Soft outlined plans to expand internationally using lessons from its national lung-cancer screening work.
Coreline Soft presented its international commercialization strategy for medical AI at the DHP 2026 digital-health summit in Seoul. CEO Jin Kook Kim described how experience from South Korea’s national lung-cancer screening program is informing the company’s overseas expansion. The company is targeting markets including Germany and France. Coreline Soft emphasized that successful healthcare AI adoption depends on integration into existing workflows and on compatibility with radiologists’ interpretation processes. The presentation highlights the operational challenge of moving AI tools from national screening programs into international healthcare systems. It also underscores the importance of workflow integration alongside model performance.
Original source: Urgent News